Supreme Court Holds Patent Board Exercised Unconstitutional Power In Inter Partes Reviews, But Leaves Many Issues Unresolved

McCarter & English, LLP

McCarter & English, LLP

Inter partes reviews (IPRs)—and other post-grant patent review proceedings at the US Patent and Trademark Office—have survived another constitutional challenge. The Supreme Court held that the authority historically exercised by administrative patent judges (APJs) in deciding IPRs is incompatible with their appointment to an inferior office. Vacating the decision by the lower appellate court, the Supreme Court found that final IPR decisions should be reviewable by the patent director. 

In United States v. Arthrex, Inc. et al., the Supreme Court held that the existing statutory structure for IPRs violated the US Constitution. Under the Appointments Clause, “[o]nly an officer properly appointed to a principal office may issue a final decision binding the [e]xecutive [b]ranch in the proceeding.” Historically, APJs issued final IPR decisions, which were unreviewable by the executive branch. But at the same time, their appointments did not comply with the Appointments Clause requirements for a principal officer. According to a majority of the Court, the violation derived from the inconsistency between APJs’ appointment and the unreviewable power they wielded. 

In the underlying decision, the Federal Circuit Court of Appeals purported to have remedied the constitutional violation by making APJs removable at will by the secretary of commerce. A majority of the Supreme Court expressly rejected that remedy, explaining that APJs are not meaningfully controlled by the threat of removal. This majority affirmed that only a principal officer may issue a final decision binding the executive branch in an IPR. 

But only a different majority of the Supreme Court reached agreement on an appropriate remedy for the violation.  That majority found that “[d]ecisions by APJs must be subject to review by the [d]irector.” It determined that the violation could be resolved by interpreting the statute to permit the director to “review final [Board] decisions and, upon review, … issue decisions himself on behalf of the Board.” It further determined that remand of the Arthrex proceeding to the director was appropriate to “provide[] an adequate opportunity for review by a principal officer.” In view of Arthrex, petitioners and patent owners dissatisfied with the APJs’ final IPR decision may now seek the director’s intervention—before any court appeal. Nonetheless, the Office must now decide, at least in the first instance, how and when a party may seek director intervention. Regardless of the answers, the new possibility of director intervention is unlikely to quickly resolve the huge backlog of IPRs that have been effectively placed on hold pending the Supreme Court’s Arthrex decision. 

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McCarter & English, LLP | Attorney Advertising

Written by:

McCarter & English, LLP

McCarter & English, LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.